Position in PYXS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,781,464
+$908,208 QoQ
Shares Held
591,849
-1.0% QoQ
Ownership
0.710%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 76 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,515,789 across 520 Biotechnology names. PYXS ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PYXS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,781,464 | 591,849 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $873,256 | 598,121 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $663,791 | 577,211 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,208,806 | 544,508 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $562,058 | 510,963 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,086,915 | 1,109,098 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,688,620 | 1,082,449 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,980,947 | 1,084,727 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,401,722 | 1,027,711 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,448,915 | 340,121 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $554,833 | 308,241 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $573,715 | 288,299 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $621,534 | 242,787 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $959,797 | 239,351 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $273,271 | 203,934 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $371,977 | 188,821 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $261,435 | 109,847 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $786,091 | 194,577 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,990,747 | 181,472 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||